Screening made easy for sleep apnoea in general practice
A new screening tool, The General Practice Sleep Scale, holds promise as a practical, real-world solution to obstructive sleep apnoea underdiagnosis in general practice.
Opinions
GPs will be a great help for managing ADHD medications. But many patients will still need specialists
The New South Wales government this week announced reforms that will allow some GPs to treat and potentially diagnose attention-deficit hyperactivity disorder (ADHD).
New global treatment guidelines for schizophrenia
The INTEGRATE project offers a concise, algorithmic guideline for schizophrenia pharmacotherapy, co-designed by global experts and those with lived experience.
Social media for doctors: popularity is not respect
Social media algorithms reward engagement, but chasing likes can cost doctors dearly, writes Dr Maria Li.
We still allow the tobacco industry to have a say in public health laws. This must stop.
Research suggests that persuasive and misleading communication practices are widely used by tobacco and vape industry actors to undermine the development of public policy that threatens their profits.
The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?
This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.
World Medical Association Statement on Physicians’ Wellbeing
The World Medical Association is taking steps to put doctors’ wellbeing front and centre with a review of their Statement on Physicians’ Wellbeing, writes Professor Steve Robson.
Human metapneumovirus joins the gang of winter respiratory viral infections
As we head into the winter months, respiratory viral infections begin to rise. This year, human metapneumovirus is poised to make an impact.
More people are trying medicinal cannabis for chronic pain. But does it work?
More Australians than ever are being prescribed medicinal cannabis.
